{"disease":{"id":"low-or-intermediate-risk-prostate-cancer","name":"low or intermediate risk prostate cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05826470","title":"Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging","phase":"NA","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Genesis Research LLC","has_results":false},{"nct_id":"NCT03935308","title":"Phase I Study MR-guided SBRT to PCa","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Henry Ford Health System","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}